Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes.
Saved in:
| Title: | Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes. |
|---|---|
| Authors: | Sundar R; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute, Singapore; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore; The N.1 Institute for Health, National University of Singapore, Singapore; Singapore Gastric Cancer Consortium, Singapore. Electronic address: mdcragh@nus.edu.sg., Chia DKA; Division of Upper Gastrointestinal Surgery, Department of Surgery, National University Hospital, National University Health System, Singapore., Zhao JJ; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute, Singapore; Department of Medicine, National University Hospital, Singapore, Singapore., Lee ARYB; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Kim G; Division of Upper Gastrointestinal Surgery, Department of Surgery, National University Hospital, National University Health System, Singapore., Tan HL; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Pang A; Division of Upper Gastrointestinal Surgery, Department of Surgery, National University Hospital, National University Health System, Singapore., Shabbir A; Division of Upper Gastrointestinal Surgery, Department of Surgery, National University Hospital, National University Health System, Singapore., Willaert W; Department of Gastrointestinal Surgery, Ghent University Hospital, Ghent, Belgium., Ma H; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore., Huang KK; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore., Hagihara T; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore., Tan ALK; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore., Ong CJ; Singapore Gastric Cancer Consortium, Singapore; Department of Sarcoma, Peritoneal and Rare Tumors (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Wong JSM; Department of Sarcoma, Peritoneal and Rare Tumors (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Seo CJ; Department of Sarcoma, Peritoneal and Rare Tumors (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Walsh R; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Chan G; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Cheo SW; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Soh CCC; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Callebout E; Department of Digestive Oncology, Gastroenterology, Ghent University Hospital, Ghent, Belgium., Geboes K; Department of Gastrointestinal Surgery, Ghent University Hospital, Ghent, Belgium., Ng MCH; Division of Medical Oncology, National Cancer Centre, Singapore; Duke NUS Medical School, Singapore., Lum JHY; Department of Pathology, National University Hospital, Singapore., Leow WQ; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore., Selvarajan S; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore., Hoorens A; Department of Pathology, Ghent University Hospital, Ghent, Belgium., Ang WH; Department of Chemistry, National University of Singapore, Singapore., Pang H; Department of Chemistry, National University of Singapore, Singapore., Tan P; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore; Singapore Gastric Cancer Consortium, Singapore., Yong WP; Department of Haematology-Oncology, National University Cancer Institute, Singapore; Singapore Gastric Cancer Consortium, Singapore., Chia CSL; Department of Sarcoma, Peritoneal and Rare Tumors (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Ceelen W; Department of Gastrointestinal Surgery, Ghent University Hospital, Ghent, Belgium., So JBY; Singapore Gastric Cancer Consortium, Singapore; Division of Upper Gastrointestinal Surgery, Department of Surgery, National University Hospital, National University Health System, Singapore; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Surgical Oncology, National University Cancer Institute of Singapore (NCIS), Singapore, Singapore. Electronic address: sursbyj@nus.edu.sg. |
| Source: | ESMO open [ESMO Open] 2024 Sep; Vol. 9 (9), pp. 103681. Date of Electronic Publication: 2024 Sep 16. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Multicenter Study |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
